APA (7th ed.) Citation

S, L., Y, H., J, Y., Z, Z., X, L., N, F., . . . Q, H. (2021). Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma–COPD Overlap in vivo and in vitro. Dove Medical Press.

Chicago Style (17th ed.) Citation

S, Li, Hui Y, Yuan J, Zhang Z, Li X, Fang N, Lin M, and Hou Q. Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma–COPD Overlap in Vivo and in Vitro. Dove Medical Press, 2021.

MLA (8th ed.) Citation

S, Li, et al. Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma–COPD Overlap in Vivo and in Vitro. Dove Medical Press, 2021.